Germline and conditional ghrelin knockout increases islet size
Journal of Clinical Investigation · 2023
DOI: 10.1172/jci175799 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Sean M Tatum und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Ghrelin, Islets of Langerhans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Conflicting studies in recent years report that genetic or pharmacological increases or decreases in ghrelin either increase or have no effect on islet size. In this issue of the JCI, Gupta, Burstein, and colleagues applied a rigorous approach to determine the effects of reducing ghrelin on islet size in germline and conditional ghrelin-knockout mice as well as across varying ages and weight. Both germline and conditional ghrelin-knockout mice associated with increased islet size, which was further exacerbated by older age and diet-induced obesity. These findings suggest that modulation of ghrelin may open a therapeutic window to prevent or treat diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NIDDK NIH HHS
Zitieren
APA
Tatum, S. M., & Holland, W. L. (2023). Germline and conditional ghrelin knockout increases islet size. Journal of Clinical Investigation. https://doi.org/10.1172/jci175799
Vancouver
Tatum SM, Holland WL. Germline and conditional ghrelin knockout increases islet size. Journal of Clinical Investigation. 2023. doi:10.1172/jci175799
BibTeX
@article{Tatum2023,
author = {Tatum, Sean M and Holland, William L},
title = {Germline and conditional ghrelin knockout increases islet size},
journal = {Journal of Clinical Investigation},
year = {2023},
doi = {10.1172/jci175799}
}
EUVIMED